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Radioimmunoassay for Plasma Testosterone
By E. NiESCHLAG1) and D. L. LORIAUX
National Institute of Child Health and Human Development^ Reproduction Research Branch, Bethesda, Maryland
(Eingegangen am 16. August/30. September 1971)
A sensitive radioimmunoassay for plasma testosterone has been developed. The antisera used were obtained by immunizing rabbits with
testosterone-3-albumin or testosterone-3-hemocyanin conjugates. Applying a new immunization technique antibodies were obtained in
high titer as early as four weeks after immunization. The standard curve of the assay extends over a wide range of dosages (0.025 to
10.0 ng). Reliability criteria are satisfactory. The assay compares favourably with competitive protein binding methods for testosterone.
Ein empfindlicher Radioimmunoassay für Plasma-Testosteron wurde entwickelt. Die verwandten Antiseren wurden durch Immuni-
sierung von Kaninchen mit Testosteron-3-Albuminr oder Testosteron-3-Hemocyanin-Konjugaten gewonnen. Unter Anwendung eines
neuen Immunisierungsverfahrens gelang es, Antikörper mit hohen Titern bereits vier Wochen nach der Immunisierung zu erhalten. Die
Standardkurve des Assays erstreckt sich über einen weiten Bereich (0,025 bis 10,0 ng). Die Verläßlichkeitskriterien der Methode sind
zufriedenstellend. Der Radioimmunoassay ist vergleichbaren kompetitiven Proteinbindungs-Methoden für Testosteron überlegen.
Attempts to produce antibodies against steroids date as
far back as 1941, when MOOSER and GRILLICHES (1)
tried to immunize animals against androstenediol
coupled to an azoprotein. Their experiments were
unsuccessful, probably because the steroid-protein-
esters were readily hydrolysed when injected into
animals. ERLANGER and coworkers (2) prepared more
stable steroid-protein-conjugates and were able to
produce antisera. Despite the availability of steroid
antibodies, however, radioimmunoassays for protein
hormones were in use for almost a decade, before the
principles of these assays were applied to steroid
determinations. The first steroid radioimmunoassay to
be described was for plasma estrogens (3). Since then,
other immunoassays for estrogens (4, 5, 6), aldosterone
(7), testosterone (8) and progesterone (9) have been
developed.
This paper presents a sensitive radioimmunoassay for
plasma testosterone using a highly potent antiserum
which was obtained by a new immunization technique.
The standard curve of the assay is useful over a wide
range of dosage.
Materials and Methods
Solvents were purchased in reagent grade from Baker Chemical Co.
and used without further purification (diethyl ether, chloroform,
methanol, ethylacetate, petroleum ether, dioxane, toluene).
Testosterone and all other steroids were obtained from Sigma
Chemical Co. Testosterone-[l,2-3H] with a specific activity of
0.25 mCi/1.6 % was supplied by the New England Nuclear Corp.
The scintillation liquid consisted of Liquiflour and toluene in a
proportion of 1:19 (v/v). Liquid scintillation counting was done
. in a Packard Tricarb scintillation spectrometer, model 4322.
A solution of 0.1% bovine gamma globulin fraction II (Schwarz/
Mann.) in 0.9% saline served as diluent (suggested by Dr. K. J.
CATT, personal communication). Precoated thin layer plates
(Silica Gel F 254, 0.25 mm, Merck AG) were used as supplied.
*) Recipient of a fellowship from the Deutsche Forschungs-
gemeinschaft.
Dextran coated charcoal consisting of 0.25% charcoal (Matheson
Scientific Corp., CX 645, lot 288) and 0.25% Dextran T-70 (Phar-
macia) in diluent was used to separate bound from free steroid.
(O-carboxymethyl)-hydroxylamine, tri-n-butylaminje and iso-
butylchlorocarbonate were purchased from K & K Laboratories,
bovine serum albumin from Armour Pharmaceutical Co. and
hemocyanin from Calbipqhem. Complete FREUND'S adjuvant
and Mycobacterium tuberculosis (killed, H 37 Ra) were supplied by
the Difco Laboratories.
Preparation of antigen
Testosterone-3-(O-carboxymethyl)-oxime was prepared from
tritiated testosterone of known low specific activity and (O-car-
boxymethyl)-hydroxylamine following the procedure of ER-
LANGER and coworkers (2). The oxime was coupled either to
bovine serum albumin or hemocyanin by a mixed anhydride
reaction (2, 10). The testosterone-3-albumin conjugate contained
9 steroid residues per molecule, while the testosterone-3-hemocy-
anin conjugate contained 190 residues per molecule (assuming a
molecular weight of 2 million for hemocyanin).
Immunisation
Immunizations were performed according to the method of
VAITUKAITIS and coworkers (11). Female New Zealand white
rabbits were used and once injected intradermally at multiple sites
with an emulsion of the testosterone conjugate, complete FREUND'S
adjuvant and additional M. tuberculosis. Two animals were inl·-
munized with 75 ^ g each of testosterone-3-albumin, and four
animals were - immunized with 100 % each of testosterone-3-
hemocyanin. Booster immunizations were not necessary.
Sample preparation
One ml of plasma from men or women was pipetted into- 13 ml
glass stoppered centrifuge tubes. 1000 cpm2) testosterone-[l,2-3H],
equivalent to 8 pg o£ testosterone arid dissolved in 50 \ methanol,
was added and incubated, for 15 min. at room temperature after
thorough mixing. The plasma then was extracted twice with 5 ml
diethyl ether from a freshly opened can. The ether phases were
transferred to another 13 ml glass tube and the extract was taken
to dryness under an air jet in a water bath of 30° C.
The residue was applied to thin layer plates with 2 75 \ me-
thanol. The plates were divided into 6 equal lanes and a testosterone
standard placed in the outer lanes. The plates were developed in
2) cpm = Counts per minute.
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chloroform/ethylacetate/petroleum ether (b, p. 60°) 50:45:5 (v/v).
The testosterone standards were located with ultraviolet light.
The silica in appropriate areas was loosened with razor blades and
aspirated by vacuum into Pasteur pipettes plugged with methanol-
washed glass wool. Testosterone was then eluted with 4ml
methanol. The residue was dried under air and rcdissolved in
1 ml methanoi. An aliquot of 0.2 ml was taken for recovery and
counted for 20 min.
Water blanks and steroid-free plasma blanks, prepared by treating
plasma with activated charcoal, were included in each assay and
handled in the same way as plasma samples.'
Radioimmunoassay
Bach assay was performed in duplicate. An aliquot of 0.1 ml
(or 0.2 ml if low testosterone levels were expected) was pipetted
into 10 χ 75mm disposable glass tubes with LANG-LEVY micro
pipettes.
Two stock solutions were used for the standard values. Solution 1
contained 1 pg testosterone per 1 μΐ methanol, solution 2 con-
tained 1 ng testosterone per 10 μ\ methanol. Standard values of
0.025, 0.05, 0.1, 0.2, and 0.5 ng were pipetted from solution 1
into the assay tubes and standard values of 1.0, 2,0, 5.0 and 10.0 ng
from solution 2.
All tubes — samples and standards — were then taken to dryncss
under an air jet. Two empty tubes were added for zero values.
Each tube then received 10,000 cpm testosterone-[l,2-3H] (equi-
valent to 80 pg testosterone) in 0.5 ml diluent. This was followed
by 0.5 ml antiserum to a dilution of 1/12500, giving a final dilution
of 1/25000 in the assay tube. Cornwall semiautomatic syringes
were used for pipetting of these two solutions.
The tubes were then agitated on a Vortex mixer and incubated for
18 hours at' 4° C. Following incubation, 0.2 ml of the dextran
coated charcoal solution was added to each tube with a Cornwall
semiautomatic syringe. This procedure was performed at 4°C. The
tubes were mixed on a Vortex mixer and centrifuged for 15 min.
at 2000 £ and 4° C.
The supernatant was decanted into counting vials containing
2.5 ml dioxane, followed by 10 ml scintillation liquid. The vials
were chilled to 4° C and counted until 10,000 counts were accumul-
ated.
Calculation of results
A logit transformation was used for calculation of the results
(12, 13). The sample values were extrapolated from a straight
line standard curve, which was obtained by plotting the logit of
(B—N)/(B0—N) X 100 against the logarithm of the dose (B =
antibody bound labeled testosterone in cpm; B0 = antibody
bound labeled testosterone at dose zero in cpm; N = nonspecific
bound labeled testosterone in cpm) (example in Fig. 1). The
assays were calculated by the computer program of RODBARD and
LEWALD (14). The standard curves were linear between 0.025 and
10.0 ng.
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Fig. 1
Standard curve in logit transformation. Ordinate = B/B0 on logit-
scale. (B = antibody bounded labelled, B0 = antibody bound
unlabelled testosterone)
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Results
Antiserum
The antigenic response of the six immunized animals
was monitored weekly by determination of the serum
dilution required to bind 50% of 10000 cpm testo-
sterone-[l,2-3H], All six rabbits produced antibodies.
As early as 4 weeks after immunization titers of 1/16000
and 1/25000 were observed in two animals. Over a
period of 10 weeks a steady increase of the titers to
dilutions of 1/128000 was observed. There was no
significant difference between animals immunized with
testosterone-3-albumin or testosterone-3-hemocyanin
conjugates.
All assays included in this paper were performed with an
antiserum obtained 4 weeks after immunization. The
serum was used at a final dilution of 1/25000.
The antiserum was preserved with 0.1% Na-azide
(final concentration)and stored at 4° C. No deterioration
of binding affinity or titer has been observed over a
period of 9 months.
The effect of time on the antigen/antibody reaction is
shown in Figure 2. At high antigen concentrations
equilibrium is reached faster than at low concentrations.
Overall, the curves flatten out after 10 hours. Therefore,
10 to 20 hours are required for incubation.
Specificity
The specificity of the antiserum was investigated by
adding other steroids to a solution containing labelled
testosterone and antiserum. The relative binding
affinity is the ratio of the amount of steroid required
to displace 50% of labelled testosterone to the
amount of testosterone required, multiplied by 100.
Dihydrotestosterone was equivalent to testosterone.
The relative binding affinities of other possible con-
taminants were: epitestosterone 0.1%, androstenediol
1.6%, and androstenedione 0.3%. All other C-18, C-19
and C-21 steroids investigated had less than 0.05%
cross reactivity (Fig. 3 and 4).
In the preparation of the samples prior to radioimmuno-
assay, dihydrotestosterone is completely separated from
testosterone by thin layer chromatography.
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Fig. 2
Effect of incubation time on the testosterone/antibody
reaction
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Fig. 3
Cross reaction of the testosterone antiserum with
other steroids. Ordinate: antibody bound labelled
testosterone as percent of cpm bound in absence of
unlabelled ligand
Testosterone 100% Dihydrotestosterone 100%
l
Epitestosterone 0.1 %
Androstenediol 1f6% Androstenedione 0,3% Dehydroepiandrosterone 0.002%
Fig, 4
Structural formulas and relative binding affinity of
the steroids investigated for cross reactivity. Circles
indicate the parts of the molecule, which are different
from testosterone
Progesterone 0.05 % 17-OH-Progesterone 0.03 % Deoxycorticosterone<0.001 %
Affinity constant, binding capacity and sensitivity
SCATCHARD plots (15) were constructed for five dose
response curves. In all cases, there was significant non-
linearity, indicating the presence of at least two "orders"
of antibodies. Using the approximate, graphical para-
meter fitting method of BERSON and YALOW (16), the
affinity constant K of the high affinity antibodies was
estimated to be 4 χ ΙΟ9 liter/mole. The affinity constant
for the low affinity antibodies was approximately
2 χ 108 liter/mole. The high affinity antibodies appeared
to constitute about 25% of the total binding capacity.
The total binding capacity was 0.1 ^ mole/liter for the
1/25000 dilution of the antiserum, which would cor-
respond to a binding capacity of 2.5 //mole/liter in the
original undiluted serum.
The binding affinity of the antibody of Κ = 4 χ ΙΟ9
liter/mole implies a theoretical sensitivity of 25 pg per
assay tube, using the approximation that the least
detectable dose is 0.1/K (17). The blank values ob-
tained from water or steroid free plasma (charcoal
treated) were between 0 and 10 pg and were not sub-
tracted from the sample values. 25 pg testosterone were
significantly different from 0.
Precision
The within-assay precision was estimated by 9 replicate
determinations of a sample under 1 jUg/1 and duplicate
determinations of 17 samples varying from 5.0 to
10.0 ^ug/1. The coefficient of variation (c. v.) for the
low concentration was 10.3% and for the high con-
centration 9.6%.
Between- ssay precision was determined by carrying a
sample from a low level pool through 6 assays and a
sample from a high level pool through 9 assays. The
Z. klin. Chem. u. klin. Biochem./ 10. Jahrg. 1972/Heft4
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c. v. for the first sample was 19% and for the second
10.8%.
Accuracy
The recovery of testosterone-[l,2-3H] from 66 samples
was 70.3 ± 6.6% (s. d.). The recovery of unkbelled
testosterone added to water was estimated from 16
values in the range of 0.05 to 1.0 ng per assay tube. The
ratio of testosterone found to that added was 100 ± 6%.
For 20 values in the range of 0.1 to 1.0 ng added to
plasma the ratio of found to added was 101 ± 12%.
Plasma values
The mean plasma testosterone value of 21 normal men,
age 21 to 44 years, was 6.37 ± 1.88 (s. d.), range
3.20—9.52//g/1 testosterone. The mean plasma value
of 7 normal women, age 19 to 22 years, was 0.57 ± 0.20,
range 0.41 to 0.98 /*g/l. In a normal man plasma values
decreased from 8.70 μ§/1 to 0.60 μg|l under massive
estrogen treatment and rose to 11.20^g/l after HCG
stimulation.
Discussion
In recent years useful methods for the measurement of
testosterone in plasma based on competitive protein
binding have been developed (for review see (18) and
(19)) and clinical studies on a larger scale were thus
facilitated (e. g. (20)). Since the reliability criteria of
these methods are satisfactory, it is pertinent to question
the necessity of radioimmunoassays for testosterone.
The binding characteristics between testosterone and
serum albumin, cortisol binding globulin, testosterone
binding globulin and the present antiserum are com-
pared in Table 1. The binding affinity (equilibrium
constant of association) for the high affinity component
of the present antiserum was 4 X 109 liter/mole. This
is approximately 10-fold higher than reported values
for the affinity of testosterone for testosterone binding
globulin (21). The 10-fold increase in affinity constant
obtained by use of the present antiserum results in a
10-fold reduction of the least detectable concentration
compared to competitive protein binding methods.
This makes it possible, for example, to measure testo-
sterone in 0.2 ml of normal female plasma. In addition,
the antibody facilitates the establishment of a standard
curve over a wide dose range, 0.025 to 10.0 ng, in this
case.
Tab. l
Binding characteristics between testosterone and albumin, cortisol
binding globulin, testosterone binding globulin and the present high
affinity antibody
In our method the within-assay precision for low and
high concentrations is essentially the samef This is
achieved by taking a larger sample aliquot, when low
levels are anticipated and thus shifting the reading to
a precise region of the standard curve.
Furthermore, the antibody offers greater specificity than
testosterone binding globulin. Testosterone binding
globulin generally shows high cross reactivity with other
17jS-hydroxy-steroids (18), whereas the antibody used
in this method cross reacts essentially with dihydro-
testosterone alone. It should be pointed out, however,
that antibodies against the same hapten may vary
considerably in specificity (22). This may explain, why
FURUYAMA and coworkers (8) using an antigen prepared
in the same way as in the present method, found only
48% cross reactivity with dihydrotestosterone.
Generally, it would appear, that the closer the structural
changes are to the site of conjugation — i. e., the 3
positions of testosterone — the less likely that they are
to be recognized by the antibody, as can be seen in
Figure 4.
The new immunization technique applied to the pro-
duction of testosterone antibodies appears far superior
to conventional methods. Useful antibodies are ob-
tained as early as 4 weeks after immunization. Addi-
tionally, higher titers are obtained, and less antigen is
required. Two testosterone-protein conjugates were
used as immunogens: testosterone-3-albumin and
testosterone-3-hemocyanin. Hemocyanin, the oxygen
transporting protein of crustaces, is well known for
its high antigenic potency, but so far only has been
applied by GROSS and coworkers (23) to produce anti-
sera against steroid hormones. In our experiments,
however, nosubstantial difference between antisera
against testosterone-3-albumin and testosterone-3-he-
mocyanin was observed.
Acknowledgements
We are grateful to Dr. M. B. LIPSETT, who provided helpful
suggestions and critical review of the manuscript, and to Dr. D.
RODBARD, who assisted with the statistical analysis.
Announcement
The testosterone antiserum is available and may be supplied to
interested investigators on application to:
Dr. E. Nieschlag
II. Medizinische Univ.-Klinik
Mooren Str. 5
D 4 D sseldorf
Germany
Binding affinity K Binding capacity(liter/mole) (mole/liter)
Albumin
Cortisol binding globulin
Testosterone binding globulin
Antibody
2 χ 104
5 χ 10«
2 χ 10»
4 χ 10»
4 χ 10-«
. 1.5 χ 10-»
2 x 10-'
2.5 χ 10-·
Dr. M. . Lipsett
Reproduction Research Branch
National Institute of Child
Health and Human Development
Bethesda
Maryland 20014
Z. klin. Chem. u. klin. Biochem./ 10. Jahrg. 1972/Heft4
168 Nieschlag and Loriaux: Radioimmunoassay for plasma testosterone
References
1. MOOSER, H. and R. K. GRILLICHES, Schweiz. Zschr. Allg.
Path. Bakt. 4, 375 (1941). — 2. ERLANGER, B. F., F. BOREK, S. M.
BEISER and S. LIEBERMAN, J. biol. Chemistry 228. 713 (1957). —
3. ABRAHAM, G. J., J. Clin. Endocr., Springfield 29, m (1969). —
4. MIKHAIL, G., C. H. Wu, M. FERIN and R. L. VANDE WIELE,
Steroids 15, 353 (1970). — 5. GURPIDE, E., M. E. GIEBENHAIN,
L. TSENG and W. G. KELLY, Amer. J. Obstet. Gynec. 109, 897
(1971). — 6. YOSHIZAWA, J. and J. FISHMAN, J. Clin. Endocr.,
Springfield 32, 3 (1971). — 7. MAYES, D., S. FÜRUYAMA, D. C. KEM
and C. A. NUGENT, J. Clin. Endocr., Springfield 30, 682 (1970). ^ -
8. FÜRUYAMA, S., D. MAYES and C. A. NUGENT, Steroids 16, 415
(1970). — 9. FÜRUYAMA, S. and C. A. NUGENT, Steroids 17, 663
(1971). — 10. VAUGHAN, J. R. and R. L. OSATO, J. Amer. ehem.
Soc. 74, 676 (1952). — 11. VAITUKAITIS, J., J. B. ROBBINS, E.
NIESCHLAG and G. T. Ross, J. Clin. Endocr., Springfield 33,
988 (1971). —12. RODBARD, D., W. BRIDSON and P. L. RAYFORD, J.
Laborat. Clin. Med., St. Louis 74, 770 (1969). — 13. WOMBACHER,
H. and E. NIESCHLAG, this journal 9,136 (1971). — 14. RODBARD,
D. and J. E. LEWALD, in E. Diczfalusy (ed.), "Steroid Aassy by
Protein Binding", Stockholm (1970) p. 79. — 15. SCATCHARD, G.,
Ann. N. Y. Acad. Sei. 51, 660 (1949). — 16. BERSON, S. A. and
R. S. YALOW, J. Clin. Invest. 38y 1996 (1959). —17. POTTS, J. T.,
L. M. SHERWOOD, J. L. H. Ö'RIORDAN and 'G. D. AUÄBACH,
Adv. Int. Med. 139 183 (1967). — 18. VERMEULEN, C. A. and
D. MAYES, in E. Diczfalusy (Ed.), "Steroid Assay by Protein
Binding", Stockholm p. 239 (1970). — 19. NUGENT, C. A. and
P. MAYES, in E. Diczfalusy (Ed.), "Steroid Assay by Protein
Binding", Stockholm p. 257 (1970). — 20. NIESCHLAG, E., M.
ROHR, H, WOMBACHER and C. OVERZIER, Klin. Wschr. 49, 91
(1971). — 21. VERMEULEN, A., L. VERDONCK, M. VAN DER
STRAETEN and N. ORIE, J. Clin. Endocr., Springfield 29y 1470
(1969). — 22. PRESSMAN, D. and A. L. GROSSBERG, in Peron, R G.
and B. V. Caldwell (Eds.), "Immunologie Methods in Steroid
Determination", New York (1970) p. 1. — 23. GROSS, S. J.,
D. H. CAMPBELL and H. H. WEETHALL, Immunochem. 59 55 (1968).
Dr. E. Nieschlag
II- Medizinische Univ.-Klinik
4000 Düsseldorf
Moorenstr. 5
Z. klin. Chem. u. klin. Biocljem./ 10. Jahrg. 1972/Heft4
Arbeitsmethoden der medizinischen
und naturwissenschaftlichen Kriminalistik
Herausgeber: Prof. Dr. med. et phil. E m i l We i n ig, Erlangen
und Professor Dr. med. Steifen Berg, Göttingen
Neuerscheinung
Band11
 Blutalkohol
und Blutwassergehalt
Methodik — Theorie — Praxis
Von H a n s - F r i e d r i c h Brettel
Professor Dr. med. Am Institut für Rechtsmedizin der
Universität Frankfurt a. M.
1972, 98 Seiten mit /Abbildungen und 12 Tabellen.
Kartoniert 36,—DM.
Das Werk bringt eine Gesamtschau zum Thema und läßt er-
kennen, daß dieses Gebiet bisher stark vernachlässigt wurde.
Dies gilt einerseits für mehr theoretische Fragen wie das Problem
des Alkoholverteilungsverhältnisses.zwischen Blut und Körper,
andererseits und vor allem jedoch für die Praxis der Blutalkohol-
Untersuchung: Auf die Bedeutung von Wassergehaltsbestimmun-
gen bei Zweit- und Nachuntersuchungen sowie bei Alkoholbe-
stimmungen von Leichenblut wird deshalb besonders eingegan-
gen. Im Zentrum des Buches steht die Darstellung der den Serum-
und Vollblutwassergehalt beeinflussenden Faktoren und der
Konsequenzen, die sich aus Störungen der Blutwasserverteilung
für das Alkoholverteilungsverhältnis in Blut und Körper ergeben.
Damit werden Probleme angeschnitten, die für die forensische
Alkoholbegutachtung wichtig sind, was das Buch für jeden Me-
diziner, der sachverständig sein will, wertvoll macht.
Bitte ausführlichen Prospekt für die Reihe anfordern.
Verlag Max Schmidt-Römhild - 2400 Lübeck 1
W
DE
G
Walter de Gruy ter
Berlin-New York
Magenoperation
und Magenoperierter
Herausgegeben von
HEINRICH BARTELHEIMEK, HANS-
JOACHIM MAURER. HANS W. SCHREIBER
unter. Mitwirkung von Kurt Müller-Wieland.
Mit 210 Abbildungen und 2 mehrfarbigen
Tafeln. Groß-Oktav. XVI, 489 Seiten. 1969.
Gänzleinen DM 88,—
ISBN 3 11 000819 X
Weitere Mitarbeiter: Volker Becker —
Hans Berndt — Kurt Diwok —
Eduard Forth m an n — Hellmuth
Fre/berger — Max Gülzow — Alfred
Gütgemann ^-Werner Koch — Klaus
Krentz — Friedrich Kuhlencordt —
Otto Lindenschmidt — Adolf
Luchmann — Fritz Meissner —Walther
Pribilla — Friedrich Stelzner —
Karl-Otto Vorläender — Egmont
Wildhirt — Ludwig Zukschwerdt
For USA and Canada:
Please send all orders to Walter de Gruyter Inc.,
162 Fifth Avenue, New York, . 10010
Disk-
Elektrophorese
analytische Trennkammer E A 90
mit komplettem oder beliebigem Zubehör
präparative Trennkammer E A100
mit synchroner Automatik bis zum Fraktionsteiler
Densitometer PHI 3 und PHI 5
für Elektrophorese und Chromatographie
Unser Gesamtprogramm
pH/mV-Meter, bioanalytische Apparaturen,
02-Meßgeräte, Konduktometer, Dekameter,
I Multi-Megohm-Meter
Fordern Sie bitte Prospekte an
bei Ihrem Fachhändler oder direkt bei uns!
Zur ANALYTICA 72
finden Sie uns in Halle 2, Stand 2102
(57)
Verschiedene
Mikrovolurnina - in
Sekunden abgeben
das kann der Hami l ton-Al iquanter . Stellen Sie die
Anschläge auf die verschiedenen V o l u m i n a e in , -
verbinden Sie den Saugarm der Spritze mit einem1*·*
Vakuum und ziehen Sie den,Kolben der Spritze^
zurück - das ist alias. Die Spritze wird automatisch
luf t f r e i qe fü l l t . Das Verfahrenjsiiggnauer (ca. ± 1 °/o
Pipet t ierung oder autonjiaTi^sch'e Dosierung -in der . ' . ;
Mämatologie, bei Ghl^id-BestimlOungen, Viejfach^^^
Enzym-Bestimmungen oder .'.Verdünnungen'? . - '
Genaueres erfahren Sie/aus^nserem Katalog, den wir
Ihnen auf anfrage gern 'zuschickend - - r " 7 - '
Bitte schreiben Sie an htemilton-Micromesure N.V.,,. .<·•'•M
Postfach 205, Den Haag, Holland. f ,? ^
m-
;·/·*-;:''
.,Üt
Autorisierter Händler für die BRD:
GÜNTHER SCHMIDT
Hamburg · Frankfurt
Aachen: Ludwig Mohren KG 6? 73021
Berlin: H. Windler KG ^»2611479
Bonn: C. Gerhardt ^ 854001
Bremen: H. Jürgens & Co. Q? 314967
Frankfurt: Wil l i Flacher KG Q? 701061
Freiburg: Bender & Hobein GmbH Q? 70349
Göttingen: Bodo Schmidt $T 56421
Hamburg: Alfred Hübscher SF 2209755
Hannover: H. Jürgens & Co. GT 15290
Karlsruhe: Bender & Hobein GmbH & 60242
Kiel: Erich Eydam S* 44464
München: Bender & Hobeln GmbH <2* 539536
Wir stellen aus:
ANALYTICA 72 (25.4. - 28.4.1972 München)
Halle 2 a, Stand 2508 a
